Suppr超能文献

使用肺动脉导管管理的重症患者的主要发病率:一项荟萃分析。

The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis.

作者信息

Ivanov R, Allen J, Calvin J E

机构信息

Section of Critical Care Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA.

出版信息

Crit Care Med. 2000 Mar;28(3):615-9. doi: 10.1097/00003246-200003000-00002.

Abstract

INTRODUCTION

The impact of pulmonary artery (PA) catheters on patient outcome has been questioned and their usage has become controversial. Meta-analysis on mortality has shown a trend for improved survival with PA catheter-guided therapy. We now perform a meta-analysis on morbidity from PA catheters in the published literature.

METHODS

We did a search of the medical database (Medline) from 1970 through 1996, using the headings "pulmonary artery catheterization," "Swan-Ganz catheterization" and "right heart catheterization," and restricting the results to "effectiveness" and "usefulness." We also consulted with other experts regarding published randomized controlled trials (RCTs). This yielded 16 RCTs addressing the question of effectiveness of PA catheter-guided treatment. Of these, 12 were found to include data on morbidity. Major morbidity, defined as organ failures as per the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria, from these trials was entered into a formal meta-analysis.

RESULTS

A total of 1,610 patients from the 12 trials were analyzed. Morbidity events were observed in 62.77% of the PA catheter treatment group, and in 74.34% of the control group. A relative risk ratio of 0.78074 was obtained, with a 95% confidence interval of 0.6459-0.94374 and a corresponding p of .0168, a lower morbidity in the PA catheter treatment group. Those with PA catheter-guided treatment had a mean protective effect of 21.9% for risk of morbidity. Other important covariates such as acuity of illness, quality score of trials, year of publication, type of PA catheter-guided treatment used (PA catheter vs. no PA catheter, or PA catheter vs. PA catheter for supranormal hemodynamic values), and surgical or mixed patient population, all increased variability and were not statistically significant predictors for risk ratio of morbidity.

CONCLUSIONS

Meta-analysis of RCTs included in this study shows that there is a statistically significant reduction in morbidity using PA catheter-guided strategies.

摘要

引言

肺动脉导管对患者预后的影响一直受到质疑,其使用也颇具争议。关于死亡率的荟萃分析显示,采用肺动脉导管引导治疗有改善生存率的趋势。我们现在对已发表文献中肺动脉导管导致的发病率进行荟萃分析。

方法

我们检索了1970年至1996年的医学数据库(Medline),使用“肺动脉导管插入术”、“Swan-Ganz导管插入术”和“右心导管插入术”等标题,并将结果限定为“有效性”和“实用性”。我们还就已发表的随机对照试验(RCT)咨询了其他专家。这产生了16项解决肺动脉导管引导治疗有效性问题的RCT。其中,发现12项包含发病率数据。根据美国胸科医师学会/危重病医学会共识会议标准,将这些试验中定义为器官衰竭的主要发病率纳入正式的荟萃分析。

结果

对12项试验中的1610名患者进行了分析。在肺动脉导管治疗组中,62.77%的患者发生了发病事件,而在对照组中这一比例为74.34%。相对风险比为0.78074,95%置信区间为0.6459 - 0.94374,相应的p值为0.0168,表明肺动脉导管治疗组的发病率较低。接受肺动脉导管引导治疗的患者发病风险平均有21.9%的保护作用。其他重要的协变量,如疾病严重程度、试验质量评分、发表年份、所采用的肺动脉导管引导治疗类型(肺动脉导管与无肺动脉导管,或肺动脉导管与用于超常血流动力学值的肺动脉导管)以及手术或混合患者群体,均增加了变异性,且不是发病率风险比的统计学显著预测因素。

结论

本研究中纳入的随机对照试验的荟萃分析表明,使用肺动脉导管引导策略可使发病率在统计学上显著降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验